Search research articles
Contact Us
Filters
Showing results (11-20 of 37) with videos related to
Page
of 4
Sort By:
Cutaneous and Ocular Toxicology
|
July 7, 2016
Safety and efficacy of autologous serum eye drop for treatment of dry eyes in graft-versus-host disease
Amir A Azari, Remzi Karadag, Mozhgan Rezaei Kanavi, et al.
American Journal of Surgery
|
August 31, 2010
Post-appendectomy visits to the emergency department within the global period: a target for cost containment
Francesco A Aiello, Erica R Gross, Aleksandra Krajewski, et al.
The Journal of Spinal Cord Medicine
|
April 27, 2021
Management of Neurogenic Bowel Dysfunction in Adults after Spinal Cord Injury Suggested citation: Jeffery Johns, Klaus Krogh, Gianna M. Rodriguez, Janice Eng, Emily Haller, Malorie Heinen, Rafferty Laredo, Walter Longo, Wilda Montero-Colon, Mark Korsten. Management of Neurogenic Bowel Dysfunction in Adults after Spinal Cord Injury: Clinical Practice Guideline for Healthcare Providers. Journal of Spinal Cord Med. 2021. Doi:10.1080/10790268.2021.1883385
Jeffery Johns, Klaus Krogh, Gianna M Rodriguez, et al.
Transplantation and Cellular Therapy
|
January 4, 2026
Financial toxicity in a phase I/II trial of LV20.19 CAR-T cell for B-cell malignancies a longitudinal, qualitative study
Elizabeth Aughey, Nirav N Shah, Cecilia J Hillard, et al.
Leukemia Research
|
July 20, 2020
Decitabine induction with myeloablative conditioning and allogeneic hematopoietic stem cell transplantation in high-risk patients with myeloid malignancies is associated with a high rate of infectious complications
Christopher R D'Angelo, Aric Hall, Kaitlin M Woo, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
August 7, 2022
Impact of Chronic Kidney Disease and Acute Kidney Injury on Safety and Outcomes of CAR T-Cell Therapy in Lymphoma Patients
Gulrayz Ahmed, Bhavna Bhasin-Chhabra, Aniko Szabo, et al.
Cancer Chemotherapy and Pharmacology
|
August 30, 2014
Acetyl-L-carnitine (ALCAR) for the prevention of chemotherapy-induced peripheral neuropathy in patients with relapsed or refractory multiple myeloma treated with bortezomib, doxorubicin and low-dose dexamethasone: a study from the Wisconsin Oncology Network
Natalie Callander, Stephanie Markovina, Jens Eickhoff, et al.
Leukemia & Lymphoma
|
August 16, 2023
TCR-α/β and CD19 depleted stem cell grafts from haploidentical donors for allogeneic transplantation in patients with relapsed lymphoma: a single-center experience
Vaishalee P Kenkre, Kristin Bradley, Arissa Milton, et al.
Journal of Surgical Education
|
January 19, 2023
So You Want to be a Program Director? Career Paths of Colon and Rectal Surgery Residency Program Directors
Andrew C Esposito, Nathan A Coppersmith, Emily A Flom, et al.
Topics in Spinal Cord Injury Rehabilitation
|
June 10, 2021
Management of Neurogenic Bowel Dysfunction in Adults after Spinal Cord Injury: Clinical Practice Guideline for Health Care Providers
Jeffery Johns, Klaus Krogh, Gianna M Rodriguez, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 37) with videos related to
Sort By:
Page
of 4
Cutaneous and Ocular Toxicology
|
July 7, 2016
Safety and efficacy of autologous serum eye drop for treatment of dry eyes in graft-versus-host disease
Amir A Azari, Remzi Karadag, Mozhgan Rezaei Kanavi, et al.
American Journal of Surgery
|
August 31, 2010
Post-appendectomy visits to the emergency department within the global period: a target for cost containment
Francesco A Aiello, Erica R Gross, Aleksandra Krajewski, et al.
The Journal of Spinal Cord Medicine
|
April 27, 2021
Management of Neurogenic Bowel Dysfunction in Adults after Spinal Cord Injury Suggested citation: Jeffery Johns, Klaus Krogh, Gianna M. Rodriguez, Janice Eng, Emily Haller, Malorie Heinen, Rafferty Laredo, Walter Longo, Wilda Montero-Colon, Mark Korsten. Management of Neurogenic Bowel Dysfunction in Adults after Spinal Cord Injury: Clinical Practice Guideline for Healthcare Providers. Journal of Spinal Cord Med. 2021. Doi:10.1080/10790268.2021.1883385
Jeffery Johns, Klaus Krogh, Gianna M Rodriguez, et al.
Transplantation and Cellular Therapy
|
January 4, 2026
Financial toxicity in a phase I/II trial of LV20.19 CAR-T cell for B-cell malignancies a longitudinal, qualitative study
Elizabeth Aughey, Nirav N Shah, Cecilia J Hillard, et al.
Leukemia Research
|
July 20, 2020
Decitabine induction with myeloablative conditioning and allogeneic hematopoietic stem cell transplantation in high-risk patients with myeloid malignancies is associated with a high rate of infectious complications
Christopher R D'Angelo, Aric Hall, Kaitlin M Woo, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
August 7, 2022
Impact of Chronic Kidney Disease and Acute Kidney Injury on Safety and Outcomes of CAR T-Cell Therapy in Lymphoma Patients
Gulrayz Ahmed, Bhavna Bhasin-Chhabra, Aniko Szabo, et al.
Cancer Chemotherapy and Pharmacology
|
August 30, 2014
Acetyl-L-carnitine (ALCAR) for the prevention of chemotherapy-induced peripheral neuropathy in patients with relapsed or refractory multiple myeloma treated with bortezomib, doxorubicin and low-dose dexamethasone: a study from the Wisconsin Oncology Network
Natalie Callander, Stephanie Markovina, Jens Eickhoff, et al.
Leukemia & Lymphoma
|
August 16, 2023
TCR-α/β and CD19 depleted stem cell grafts from haploidentical donors for allogeneic transplantation in patients with relapsed lymphoma: a single-center experience
Vaishalee P Kenkre, Kristin Bradley, Arissa Milton, et al.
Journal of Surgical Education
|
January 19, 2023
So You Want to be a Program Director? Career Paths of Colon and Rectal Surgery Residency Program Directors
Andrew C Esposito, Nathan A Coppersmith, Emily A Flom, et al.
Topics in Spinal Cord Injury Rehabilitation
|
June 10, 2021
Management of Neurogenic Bowel Dysfunction in Adults after Spinal Cord Injury: Clinical Practice Guideline for Health Care Providers
Jeffery Johns, Klaus Krogh, Gianna M Rodriguez, et al.
Page
of 4